Department of Biochemistry, NYU Langone Medical Center, 550 First Avenue, New York, New York 10016, USA.
Cytoskeleton (Hoboken). 2010 Nov;67(11):706-14. doi: 10.1002/cm.20480.
Assembly of the α/β tubulin heterodimer requires the participation of a series of chaperone proteins (TBCA-E) that function downstream of the cytosolic chaperonin (CCT) as a heterodimer assembly machine. TBCD and TBCE are also capable of acting in a reverse reaction in which they disrupt native heterodimers. Homologs of TBCA-E exist in all eukaryotes, and the amino acid sequences of α- and β-tubulin isotypes are rigidly conserved among vertebrates. However, the efficiency with which TBCD effects tubulin disruption in vivo depends on its origin: bovine (but not human) TBCD efficiently destroys tubulin and microtubules upon overexpression in cultured cells. Here we show that recombinant bovine TBCD is produced in HeLa cells as a stoichiometric cocomplex with β-tubulin, consistent with its behavior in vitro and in vivo. In contrast, expression of human TBCD using the same host/vector system results in the generation of TBCD that is not complexed with β-tubulin. We show that recombinant human TBCD functions indistinguishably from its nonrecombinant bovine counterpart in in vitro CCT-driven folding reactions, in tubulin disruption reactions, and in tubulin GTPase activating protein assays in which TBCD and TBCC stimulate GTP hydrolysis by β-tubulin at a heterodimer concentration far below that required for polymerization into microtubules. We conclude that bovine and human TBCD have functionally identical roles in de novo tubulin heterodimer assembly, and show that the inability of human TBCD to disrupt microtubule integrity upon overexpression in vivo can be overcome by siRNA-mediated suppression of expression of the TBCD regulator Arl2 (ADP ribosylation factor-like protein).
α/β 微管蛋白异二聚体的组装需要一系列伴侣蛋白(TBCA-E)的参与,这些伴侣蛋白作为异二聚体组装机器,在细胞质伴侣素(CCT)下游发挥作用。TBCD 和 TBCE 也能够在反向反应中发挥作用,破坏天然异二聚体。TBCA-E 的同源物存在于所有真核生物中,并且脊椎动物中的α-和β-微管蛋白同工型的氨基酸序列是严格保守的。然而,TBCD 在体内破坏微管的效率取决于其来源:在培养细胞中过度表达时,牛(而非人)TBCD 有效地破坏微管和微管蛋白。在这里,我们表明重组牛 TBCD 在 HeLa 细胞中作为β-微管蛋白的化学计量共复合物产生,这与其在体外和体内的行为一致。相比之下,使用相同的宿主/载体系统表达人 TBCD 会导致与β-微管蛋白不复合的 TBCD 的产生。我们表明,重组人 TBCD 在体外 CCT 驱动的折叠反应、微管蛋白破坏反应以及微管蛋白 GTP 酶激活蛋白测定中,与非重组牛 TBCD 具有相同的功能,其中 TBCD 和 TBCC 在远低于聚合形成微管所需的异二聚体浓度下刺激β-微管蛋白的 GTP 水解。我们得出结论,牛和人 TBCD 在从头开始的微管蛋白异二聚体组装中具有功能相同的作用,并表明人 TBCD 在体内过度表达时无法破坏微管蛋白完整性,这可以通过 siRNA 介导的 TBCD 调节因子 Arl2(ADP 核糖基化因子样蛋白)表达的抑制来克服。